Stock Performance and Market Context
On 30 March 2026, Meghmani Organics Ltd opened with a gap down of 4.77%, closing the day with a loss of 5.86%. The stock touched an intraday low of Rs.37, setting a fresh 52-week and all-time low. This decline extended a three-day losing streak, during which the stock has fallen by 11.87%. Over the same period, the sector of Dyes & Pigments declined by 3.24%, while the Sensex dropped 2.12%, underscoring Meghmani Organics’ relative underperformance.
Meghmani Organics is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a sustained bearish trend. The stock’s performance over various time frames further highlights its challenges: a 1-month return of -26.49% versus Sensex’s -10.24%, a 3-month return of -41.35% compared to Sensex’s -14.94%, and a year-to-date decline of 42.32% against the Sensex’s 15.49% fall.
Financial Metrics and Profitability Concerns
Meghmani Organics’ financial indicators reveal a company grappling with profitability and debt servicing issues. The latest quarterly profit after tax (PAT) stood at a loss of Rs.3.53 crores, representing a steep fall of 135.6% compared to the previous four-quarter average. Meanwhile, interest expenses for the nine months ended have risen by 22.18% to Rs.71.38 crores, exerting additional pressure on earnings.
The operating profit to interest ratio for the quarter is at a low of 2.08 times, indicating limited cushion to cover interest obligations. The company’s average EBIT to interest ratio over recent years is negative at -5.58, reflecting ongoing difficulties in generating sufficient operating earnings to meet debt costs.
Return on equity (ROE) remains subdued at an average of 6.03%, signalling modest profitability relative to shareholders’ funds. Similarly, the return on capital employed (ROCE) is weak at 4.6%, although the valuation metrics suggest the stock is trading at a discount with an enterprise value to capital employed ratio of 0.77x.
Long-Term Growth and Quality Assessment
Over the past five years, Meghmani Organics has experienced a compound annual growth rate (CAGR) decline of 17.31% in operating profits, underscoring persistent challenges in expanding its core earnings. Sales growth over the same period has been minimal at 1.18%, while the company’s capital structure and management risk have been assessed as below average.
The company maintains a low debt to EBITDA ratio of 0.93, indicating moderate leverage, and has no promoter share pledging. However, institutional holdings remain low at 1.38%, and domestic mutual funds hold no stake, which may reflect limited confidence in the company’s current valuation or business outlook.
Valuation and Technical Indicators
Meghmani Organics’ valuation multiples as of 30 March 2026 show a price-to-earnings (P/E) ratio of 25x and a price-to-book value (P/BV) of 0.65x, suggesting the stock is trading below its book value. The enterprise value to EBITDA multiple stands at 8.11x, while the EV/EBIT ratio is 17.47x. The PEG ratio is notably low at 0.13x, reflecting the disparity between price and earnings growth.
Technically, the stock is in a bearish trend since 14 November 2025, when it broke below Rs.72.18. Weekly and monthly indicators such as MACD, Bollinger Bands, and KST are predominantly bearish, with the relative strength index (RSI) showing mixed signals. Immediate support is identified at Rs.41.27, the 52-week low prior to the recent fall, while resistance levels lie at Rs.45.14 (20-day moving average) and Rs.59.13 (100-day moving average).
Trading Activity and Market Capitalisation
Trading volumes have increased notably, with delivery volumes rising by 103.28% over the past month and a 60.16% increase in delivery volume on the day of the price fall compared to the five-day average. Despite this activity, Meghmani Organics remains classified as a small-cap company within the Pesticides & Agrochemicals sector.
The stock’s underperformance is stark when compared to the BSE500 index, with negative returns in each of the last three annual periods and a cumulative three-year decline of 51.91%, while the Sensex has gained 24.26% over the same timeframe.
Summary of Key Financial and Market Data
• Latest Price: Rs.37.08 (All-time low)
• Market Cap Grade: Small-cap
• Mojo Score: 14.0 (Strong Sell, downgraded from Sell on 1 January 2026)
• 52-Week Range: Rs.41.27 – Rs.106.03
• Dividend: Rs.1.4 per share (last ex-dividend date 20 June 2023)
• Debt to EBITDA: 0.93 (Low leverage)
• Average ROCE: 7.62% (Weak)
• Average ROE: 6.03% (Weak)
• PAT Quarterly: Rs.-3.53 crores (-135.6%)
• Interest (9M): Rs.71.38 crores (+22.18%)
• Operating Profit to Interest (Q): 2.08 times (Lowest)
• Sales Growth (5Y): 1.18% CAGR
• EBIT Growth (5Y): -17.31% CAGR
Meghmani Organics Ltd’s stock performance and financial indicators reflect a company facing significant headwinds, with its share price reaching unprecedented lows amid a sustained downtrend. The data highlights ongoing pressures on profitability, earnings growth, and market valuation within the context of a challenging sector environment.
